Leadership Overview
Ipsen has 4 executives leading key functions including finance, marketing, and quality.
Driven by a commitment to specialty care, Ipsen develops and commercializes medicines in oncology, neuroscience, and rare diseases, impacting global health outcomes.
Driven by a commitment to specialty care, Ipsen develops and commercializes medicines in oncology, neuroscience, and rare diseases, impacting global health outcomes.
Leadership Roles at Ipsen
Gonzalo Colimodio - Chief Financial Officer
Gonzalo Colimodio, the Chief Financial Officer at Ipsen, directs the company's financial strategy and operations. This leadership role involves managing all fiscal activities, including budgeting, forecasting, and financial reporting, ensuring robust financial health for the biopharmaceutical group. Colimodio oversees the allocation of capital to support research and development initiatives in oncology, neuroscience, and rare diseases, aligning financial resources with strategic growth objectives. The Chief Financial Officer's oversight extends to investor relations and maintaining strong relationships with financial stakeholders, crucial for securing investment and driving long-term value. By optimizing financial performance, Gonzalo Colimodio directly contributes to Ipsen's mission of delivering innovative treatments to patients worldwide. This executive's focus ensures fiscal discipline and supports the expansion of the company's specialty care portfolio across key global markets.
Andrew Singer - Executive Vice President & Chief Financial Officer
Andrew Singer, the Executive Vice President & Chief Financial Officer at Ipsen, provides critical financial leadership and strategic direction for the global biopharmaceutical group. This senior role encompasses the comprehensive management of Ipsen's financial architecture, including capital allocation, financial planning, and risk management, supporting the company's focus on oncology, neuroscience, and rare diseases. Singer's oversight ensures that financial operations are optimized to fuel innovation and commercial success across key therapeutic areas. The Executive Vice President & Chief Financial Officer's influence extends to shaping corporate financial policy and driving efficiency throughout the organization. By guiding financial strategy, Andrew Singer plays a vital part in enhancing shareholder value and enabling the development and delivery of life-changing specialty care medicines. This executive's expertise underpins Ipsen's sustained growth and market position.
Koceir Hichem - Chief Marketing Officer, Quality
Koceir Hichem, the Chief Marketing Officer, Quality at Ipsen, spearheads the strategic marketing initiatives and ensures the highest standards of quality across the organization. This dual focus involves developing and executing comprehensive marketing plans for Ipsen's specialty care medicines in oncology, neuroscience, and rare diseases, driving market penetration and patient access. Hichem's responsibilities include overseeing quality assurance and control processes, guaranteeing that all products meet stringent regulatory and safety requirements. The Chief Marketing Officer, Quality's role is pivotal in translating scientific innovation into commercially successful therapies, fostering strong brand recognition and market leadership. By integrating marketing acumen with a rigorous quality framework, Koceir Hichem ensures that Ipsen delivers both effective treatments and maintains unwavering product integrity. This executive's leadership supports the company's global reach and commitment to patient well-being.
Farida Bouziane - Chief Marketing Officer & Manager, Quality Snior & , Africa (North)
Farida Bouziane, the Chief Marketing Officer & Manager, Quality Snior & , Africa (North) at Ipsen, directs marketing strategies and quality management within the North African region, alongside broader organizational quality oversight. This executive's mandate involves tailoring Ipsen's specialty care offerings in oncology, neuroscience, and rare diseases to meet the specific needs of the North African market, driving commercial success and patient access. Bouziane's leadership ensures adherence to stringent quality standards, guaranteeing the integrity and efficacy of Ipsen's pharmaceutical products in the region and beyond. The Chief Marketing Officer & Manager, Quality Snior & , Africa (North)'s role is essential for expanding Ipsen's footprint and impact in diverse geographies. By combining regional marketing expertise with a deep commitment to quality, Farida Bouziane strengthens Ipsen's reputation and operational excellence. This executive's focus supports the company's global mission to improve patient lives through innovative treatments.
Explore Leadership Teams in Manufacturing
PharmaLogic Holdings Corp. is a global contract development and manufacturing organization (CDMO) specializing in diagnostic and therapeutic radiopharmaceuticals. Through a network of radiopharmacies and manufacturing facilities across North America and Europe, it develops, manufactures, and distributes clinical and commercial radiopharmaceutical products to pharmaceutical partners and healthcare providers.
Company Leadership
GP
MD
HP
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing. Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, solid-state science, material characterization, stability storage, and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile, and non-sterile ointments.
Company Leadership
BB
RL
Shionogi & Co., Ltd. is a Japanese pharmaceutical company dedicated to developing innovative treatments that improve patient lives worldwide. With a longstanding focus on addressing pressing global health challenges, the company has been a pioneer in discovering and delivering novel therapies for infectious diseases, including antibiotics, HIV, influenza, and emerging viral threats such as COVID-19. Shionogi combines in-house research and development with strategic collaborations across industry, government agencies, biotech companies, and academic institutions to accelerate the advancement of its scientific programs and bring meaningful therapies to patients with urgency and precision.
Company Leadership
TK
MF
TN
21st Century Vitamins operates as a globally recognized manufacturer and distributor of dietary supplements, positioned within the broader health and wellness industry. The company, through its parent entity 21st Century HealthCare, Inc., focuses on developing, producing, and delivering a wide range of vitamins, minerals, herbal supplements, and specialty nutritional products designed to support everyday health and well-being. With a history spanning more than three decades, the organization has established itself as a trusted and accessible brand in the consumer healthcare market. At its core, the company functions as both a manufacturer and a direct-to-consumer wellness provider. It produces an extensive portfolio of dietary supplements that cater to diverse health needs, including general nutrition, immune support, cardiovascular health, digestive wellness, sports nutrition, and beauty supplements. Its offerings range from traditional multivitamins and single-nutrient formulations to advanced blends such as amino acids, probiotics, and plant-based supplements. This breadth of product categories reflects the companys strategy of addressing a wide spectrum of consumer health requirements through scientifically formulated solutions.
Company Leadership SS
FC
KW
Frequently Asked Questions Regarding Ipsen Top Executives and Leadership Team
